Clinical Trial Update: Self Assembling Peptide P11-4 in Patients With Early Occlusal Carious Lesions [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating self-assembling peptide P11-4 for early occlusal carious lesions completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Caries

Drugs mentioned

• P11-4

Snippet

Sponsor: University Medicine Greifswald | Conditions: Dental Caries | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-04-08